Moderna Raises Year-End 2026 Cash and Investments Outlook
Moderna now expects year-end 2026 cash and investments of about $8.1B-$8.3B, versus its prior view of $4.7B-$5.2B.
Related stories
Telephone & Data Systems Sees 2026 TDS Telecom Adjusted EBITDA of $290M–$310M
M impact | EARNINGS | Nov 06, 2026, 12:39 PM UTC
Telephone & Data Systems Sees 2026 TDS Telecom Revenue at $990M-$1.01B
M impact | EARNINGS | Nov 06, 2026, 12:38 PM UTC
Ubiquiti Networks earnings above expectations at 5.32 USD
Ubiquiti Networks (UBNT) released earnings per share at 5.32 USD, compared to market expectations of 4.32 USD.
H impact | EARNINGS | Nov 06, 2026, 12:37 PM UTC
Aegis Brands Reports C$35.4M in Third-Quarter Sales
M impact | EARNINGS | Nov 06, 2026, 12:34 PM UTC
PPL Updated Business Plan Sees About $3 Billion in Equity Financing Needs
M impact | EARNINGS | Nov 06, 2026, 12:34 PM UTC
Moderna Swings to Third-Quarter Profit and Raises Full-Year Revenue Outlook
Moderna reported a profit in the recent quarter and lifted its full-year revenue forecast as international demand for its Covid-19 vaccines stabilized.
M impact | EQUITY | Nov 06, 2026, 12:33 PM UTC